Literature DB >> 6621954

Psychosocial reactions to the diagnosis of gynecologic cancer.

E N Cain, E I Kohorn, D M Quinlan, P E Schwartz, K Latimer, L Rogers.   

Abstract

Data are presented on the psychosocial impact of gynecologic cancer derived from both a structured interview and self-report scales administered to 60 women newly diagnosed with cervical, uterine, and ovarian malignancies. Findings show that such women experience mild to moderate symptoms of depression and anxiety, as well as impairment of vocational, domestic, and sexual functioning. The women with cancer reported significantly fewer symptoms of depression and social impairment than acutely depressed women without cancer. The women studied also demonstrated significantly more symptoms of depression and social impairment than women without psychiatric disease from randomly selected community samples. The symptoms of depression experienced by women with ovarian cancer, women receiving triple-agent chemotherapy and women with poorly differentiated tumors of the endometrium and ovary approached the level of acute symptoms typically reported by women entering outpatient psychiatric clinics. These observations should enhance the understanding of these problems among gynecologists and other health care providers in offering appropriate psychosocial support for women with gynecologic cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6621954

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  A digital media attention diversion improves mood and fear in patients receiving chemotherapy for recurrent gynecologic malignancies: results of a randomized trial.

Authors:  Ryan Spencer; Vinita Alexander; Jens Eickhoff; Kaitlin Woo; Erin Costanzo; Nick Marx; Stephen Rose
Journal:  Int J Gynecol Cancer       Date:  2020-03-01       Impact factor: 3.437

3.  Psychiatric morbidity in outpatients of gynecological oncology clinic in a tertiary care hospital.

Authors:  Rohan Dilip Mendonsa; Prakash Appaya
Journal:  Indian J Psychiatry       Date:  2010-10       Impact factor: 1.759

4.  Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers.

Authors:  Sharon Manne; Shannon Myers; Melissa Ozga; David Kissane; Debby Kashy; Stephen Rubin; Carolyn Heckman; Norm Rosenblum
Journal:  Gen Hosp Psychiatry       Date:  2013-10-09       Impact factor: 3.238

5.  Psychosomatic Aspects of Gynecologic Oncology: Present Status and Future Directions.

Authors:  Barbara L Andersen; Barrie Anderson
Journal:  J Psychosom Obstet Gynaecol       Date:  1986-12-01       Impact factor: 2.949

6.  Right Place, Right Time: Preferences of Women with Ovarian Cancer for Delivery of CAM Education.

Authors:  Judith Ann Ebbert; Kristine A Donovan; Cecile A Lengacher; Donna Fabri; Richard Reich; Ellen Daley; Erika Lynne Thompson; Robert M Wenham
Journal:  Medicines (Basel)       Date:  2015-08-31

Review 7.  Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.

Authors:  Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin
Journal:  Cancer Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.592

8.  Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.

Authors:  Giovanna Mantegna; Marco Petrillo; Gilda Fuoco; Laura Venditti; Serena Terzano; Luigi Pedone Anchora; Giovanni Scambia; Gabriella Ferrandina
Journal:  BMC Cancer       Date:  2013-03-18       Impact factor: 4.430

9.  A longitudinal investigation of psychological morbidity in patients with ovarian cancer.

Authors:  V Gonçalves; G Jayson; N Tarrier
Journal:  Br J Cancer       Date:  2008-11-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.